Search Results - "Tesei, S."
-
1
Evaluation of LRRK2 G2019S penetrance : Relevance for genetic counseling in Parkinson disease
Published in Neurology (03-04-2007)“…We report the results of a family-based study of LRRK2 G2019S penetrance in Parkinson disease. We studied 19 families identified through the analysis of…”
Get full text
Journal Article -
2
Zinc, metallothioneins and longevity: interrelationships with niacin and selenium
Published in Current pharmaceutical design (01-09-2008)“…Ageing is an inevitable biological process with gradual and spontaneous biochemical and physiological changes and increased susceptibility to diseases. Some…”
Get more information
Journal Article -
3
Efficacy of rasagiline and selegiline in Parkinson’s disease: A head-to-head 3-year retrospective case-control study
Published in Parkinsonism & related disorders (01-01-2018)Get full text
Journal Article -
4
647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications
Published in Molecular genetics and metabolism (01-05-2008)“…Diabetes mellitus is a chronic disease characterized by an overproduction of reactive oxygen species, which perturbs zinc metabolism and promotes the onset of…”
Get full text
Journal Article -
5
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson’s disease and originates from a common ancestor
Published in Journal of medical genetics (01-11-2005)“…Background: Mutations in the gene Leucine-Rich Repeat Kinase 2 (LRRK2) were recently identified as the cause of PARK8 linked autosomal dominant Parkinson’s…”
Get full text
Journal Article -
6
Session 2: Micronutrients and the immune system Zinc, metallothioneins and immunosenescence
Published in Proceedings of the Nutrition Society (01-08-2010)Get full text
Conference Proceeding -
7
Zinc, metallothioneins and immunosenescence
Published in Proceedings of the Nutrition Society (01-08-2010)“…Ageing is an inevitable biological process with gradual and spontaneous biochemical and physiological changes and increased susceptibility to diseases. The…”
Get full text
Journal Article -
8
PP213-SUN: Swallowing Disturbances in Parkinson’s Disease
Published in Clinical nutrition (Edinburgh, Scotland) (01-09-2014)Get full text
Journal Article -
9
-
10
Hydrocarbon exposure and Parkinson's disease
Published in Neurology (12-09-2000)“…Single cases of parkinsonism have been associated with hydrocarbon solvents. To determine whether exposure to hydrocarbon solvents is related to PD. Cohort…”
Get full text
Journal Article -
11
An overnight switch to ropinirole therapy in patients with Parkinson's disease
Published in Journal of Neural Transmission (01-01-1999)Get full text
Journal Article -
12
Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease
Published in The New England journal of medicine (04-01-2007)“…A cohort of patients with Parkinson's disease treated with either ergot-derived or non–ergot-derived dopamine agonists underwent echocardiographic evaluation…”
Get full text
Journal Article -
13
Dopamine dysregulation syndrome in Parkinson's disease: from clinical and neuropsychological characterisation to management and long-term outcome
Published in Journal of neurology, neurosurgery and psychiatry (01-03-2014)“…Objective Dopamine dysregulation syndrome (DDS) refers to a compulsive pattern of dopaminergic drug misuse complicating Parkinson's disease (PD). To date, few…”
Get full text
Journal Article -
14
123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy
Published in Neurological sciences (01-10-2003)“…We used SPECT and the tracer (123)I-Ioflupane to measure dopamine transporter (DAT) binding in the caudate nucleus and the putamen of 70 patients with…”
Get full text
Journal Article -
15
Pramipexole versus sertraline in the treatment of depression in Parkinson's disease : A national multicenter parallel-group randomized study
Published in Journal of neurology (01-05-2006)“…In addition to treating the motor symptoms of Parkinson's disease, the dopamine agonist pramipexole has shown an antidepressant effect. The trials, however,…”
Get full text
Journal Article -
16
PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum
Published in Human mutation (01-04-2008)“…Heterozygous rare variants in the PINK1 gene, as well as in other genes causing autosomal recessive parkinsonism, have been reported both in patients and…”
Get full text
Journal Article -
17
Association of MT1A haplotype with cardiovascular disease and antioxidant enzyme defense in elderly Greek population: comparison with an Italian cohort
Published in The Journal of nutritional biochemistry (01-10-2010)“…Metallothioneins (MT), the antioxidant zinc-binding proteins, seem to mediate cardioprotection. It has been postulated that zinc homeostasis and MT function…”
Get full text
Journal Article -
18
Madopar HBS in fluctuating parkinsonian patients: two-year treatment
Published in Movement disorders (1988)“…In an open-label study, we substituted conventional levodopa plus benserazide: 100/25 (Madopar) with a controlled-release form (HBS) in 18 fluctuating…”
Get more information
Journal Article -
19
Tolerability of paroxetine in Parkinson's disease: A prospective study
Published in Movement disorders (01-09-2000)“…Depression is a common finding in patients with Parkinson's disease (PD). Traditionally, depression has been treated with tricyclic antidepressants, which are…”
Get full text
Journal Article -
20
l-Arginine normalizes NOS activity and zinc-MT homeostasis in the kidney of mice chronically exposed to inorganic mercury
Published in Toxicology letters (28-09-2009)“…Inorganic mercury (HgCl 2) exposure provokes damage in many organs, especially kidney. Inducible nitric oxide synthase (iNOS) expression, total NOS activity…”
Get full text
Journal Article